Outcome of cell suspension allografts in a patient with Huntington's disease-Reference-Cited by-同舟云学术

Outcome of cell suspension allografts in a patient with Huntington's disease

Published:2018-10-25 Issue:6 Volume:84 Page:950-956
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Maxan Alexander¹,Mason Sarah²,Saint-Pierre Martine¹,Smith Emma²,Ho Aileen²,Harrower Timothy³,Watts Colin²,Tai Yen²,Pavese Nicola⁴,Savage Julie C.¹⁵,Tremblay Marie-Ève¹⁵,Gould Peter⁶,Rosser Anne E.⁷,Dunnett Stephen B.⁷,Piccini Paola⁴,Barker Roger A.²,Cicchetti Francesca¹⁸

Affiliation:

1. Centre de Recherche du CHU de Québec (CHUQ), Axe Neurosciences; Québec QC Canada

2. John van Geest Centre for Brain Repair and Department of Clinical Neuroscience; University of Cambridge; Cambridge United Kingdom

3. Royal Devon and Exeter Hospital; Barrack Road, Exeter Devon United Kingdom

4. Department of Medicine; Neurology Imaging Unit, Imperial College London; London United Kingdom

5. Département de médecine moléculaire; Université Laval; Québec QC Canada

6. Laboratoire de neuropathology, Hôpital de l'Enfant-Jésus-CHU de Québec; Québec QC United Kingdom

7. Brain Repair Group and BRAIN unit, Neuroscience and Mental Health Research Institute and School of Biosciences; Cardiff University; Cardiff United Kingdom

8. Département de Psychiatrie & Neurosciences; Université Laval; Québec QC Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.25354/fullpdf

Reference26 articles.

1. Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature;Mason;Expert Opin Pharmacother,2016

2. Functional integration of striatal allografts in a primate model of Huntington's disease;Kendall;Nat Med,1998

3. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease;Bachoud-Levi;Exp Neurol,2000

4. NEST-UK. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475;Rosser;J Neurol Neurosurg Psychiatry,2002

5. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease;Barker;J Neurol Neurosurg Psychiatry,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases;Neurobiology of Disease;2024-08

2. Inflammation and Huntington’s disease – a neglected therapeutic target?;Expert Opinion on Investigational Drugs;2024-05-03

3. Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-03-29

4. The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cellsin vitro: implications for the STEM-PD clinical trial;2024-01-24

5. Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease;Neurobiology of Disease;2024-01